Found 410 matching trials
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE PHASE4 The objectives of the study were:
1. To assess the safety and tolerability...
Show More Location
Allergy, Asthma and Immunology Associates
Learn More & Join Trial
Trial of High-Dose Rifampin in Patients With TB PHASE2 The purpose of this study is to evaluate the potential of high doses of rif...
Show More Location
University of Florida
Learn More & Join Trial
Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes PHASE4 Tuberculosis (TB) is a leading cause of death in HIV-infected individuals. ...
Show More Location
Infectious Diseases Institute
Learn More & Join Trial
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines PHASE1 The purpose of the study is to develop a BCG challenge model for use in sho...
Show More Location
Fred Hutchinson Cancer Center
Learn More & Join Trial
A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema PHASE1 This is a Phase 1/2, single-arm, open-label, dose-escalation and dose-expan...
Show More Status
Active Not Recruiting
Location
AllerVie Clinical Research
Learn More & Join Trial
Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis PHASE2 AlpE is a novel drug combination under development for the treatment of TB,...
Show More Location
Multiple Locations
Learn More & Join Trial
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 PHASE4 In countries with a high tuberculosis (TB) prevalence, TB and invasive bact...
Show More Location
Sihanouk Hospital Center of Hope
Learn More & Join Trial
The Safety of Tuberculosis Treatments by Oral Inhalation PHASE1 The inhaled route of delivery has always been associated with the considera...
Show More Location
Songklanagarind Hospital
Learn More & Join Trial
Novel Triple-dose Tuberculosis Retreatment Regimen PHASE3 To determine if a high-dose first-line regimen is non-inferior (non-inferio...
Show More Location
Damien Foundation
Learn More & Join Trial
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients PHASE3 This is a double-blind, randomized-withdrawal, placebo-controlled study in ...
Show More Location
University of Alabama Hospital (at Birmingham)
Learn More & Join Trial